Agios Pharmaceuticals, Inc.

NASDAQ:AGIO

47.38 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011
Assets:
Current Assets:
Cash & Cash Equivalents 88.205139.259203.126127.43680.931805.421567.75573.564375.90714.03171.5691.297117.661
Short Term Investments 688.723643.86816.892445.493483.946514.8321.212380.56245.238328.03495.20936.67961.507
Cash and Short Term Investments 776.9281,096.9931,286.393670.537564.877805.421567.75573.564375.907342.065166.769127.976179.168
Net Receivables 2.812.2064.37825.39915.31910.4423.8398.31411.59912.6670.47600
Inventory 19.0768.49216.1914.6987.3310.869-143.814-32.25-58.9050000
Other Current Assets 35.02138.95511.816-73.95724.17717.16717.48610.2648.7284.8142.5022.16811.417
Total Current Assets 833.835832.7721,064.231636.677611.704613.78445.261559.892337.329359.546169.747130.144190.585
Non-Current Assets:
Property, Plant & Equipment, Net 69.79188.116104.23117.542126.10824.3224.43125.33723.226.3863.7583.5653.222
Goodwill 0000000000000
Intangible Assets 0000000000000
Goodwill and Intangible Assets 0000000000000
Long Term Investments 29.435313.874266.37597.608152.929220.119143.81432.2558.905125.38227.12500
Tax Assets 000000000002.7060.037
Other Non-Current Assets 4.0573.9562.91.125-279.0370.2380.8911.6150.6110.590.5750.5930.626
Total Non-Current Assets 103.283405.946373.505216.275279.037244.677169.13659.20282.736132.35831.4586.8643.885
Total Assets 937.1181,238.7181,437.736852.952890.741858.457614.397619.094420.065491.904201.205137.008194.47
Liabilities & Equity:
Current Liabilities:
Account Payables 9.7818.61616.726.84421.89617.8822.76717.10614.74811.0673.6783.3083.573
Short Term Debt 15.00813.66311.1597.416.915-59.809-125.798-154.297-4.69914.338.1716.66819.458
Tax Payables 0000000003.8411.4624.87517.867
Deferred Revenue 000010.93392.519163.64190.2124.36435.68625.07225.07225.072
Other Current Liabilities 43.16730.3531.96760.1453.14242.91334.33235.41418.4750.0060.0090.0650.055
Total Current Liabilities 67.95562.62959.82694.39492.88693.50394.94188.43352.88861.08936.9335.11348.158
Non-Current Liabilities:
Long Term Debt 56.98871.99685.93597.789106.74700000000
Deferred Revenue Non-Current 000261.26950.5859.809125.798154.2974.6992.72532.56757.63982.711
Deferred Tax Liabilities Non-Current 000-261.269-50.5800000000
Other Non-Current Liabilities 1.1563.2790261.26950.5817.60818.15517.77317.363.7240.2260.3580.461
Total Non-Current Liabilities 58.14475.27585.935359.058157.32777.417143.953172.0722.0596.44932.79357.99783.172
Total Liabilities 126.099137.904145.761453.452250.213170.92238.894260.50374.94767.53869.72393.11131.33
Equity:
Preferred Stock 0000000000201.205115.922115.922
Common Stock 0.0720.0710.0710.0690.0680.0580.0490.0420.0380.0370.0310.0030.003
Retained Earnings -822.649-470.561-238.76-1,843.475-1,516.105-1,104.633-798.061-483.151-284.68-166.948-113.444-74.037-53.935
Accumulated Other Comprehensive Income/Loss -0.441-12.535-1.1980.1050.202-2.171-1.389-0.313-0.318-0.0570.014-0.0020.023
Other Total Stockholders Equity 1,634.0371,583.8391,531.8622,242.8012,156.3631,794.2831,174.904842.013630.078591.33443.6762.0121.127
Total Shareholders Equity 811.0191,100.8141,291.975399.5640.528687.537375.503358.591345.118424.366131.48243.89863.14
Total Equity 811.0191,100.8141,291.975399.5640.528687.537375.503358.591345.118424.366131.48243.89863.14
Total Liabilities & Shareholders Equity 937.1181,238.7181,437.736852.952890.741858.457614.397619.094420.065491.904201.205137.008194.47